Cluster: Archive

Banking secrecy remains a business model for Swiss banks

This content was published on Feb 5, 2021 Swiss officials have discovered CHF9 billion in embezzled Venezuelan public funds spread across hundreds of bank accounts.

Beny Steinmetz case shows how hard it is to prove corruption

This content was published on Feb 5, 2021 The Guinea mining scandal illustrates the ease with which officials can sell their nation’s treasure.

‘The virus is always evolving’

This content was published on Feb 5, 2021 Should we be afraid of virus variants? Will vaccines be effective against new virus forms? Genomic epidemiologist Emma Hodcroft offers some insight.

Protecting livestock from predators costs Swiss taxpayers millions

This content was published on Feb 4, 2021 The federal government spends CHF4 million (around $4.4 million) a year to minimise the damage caused by predators like wolves and lynx.

Alpine exposure: how good are our survival tactics?

This content was published on Feb 4, 2021 What did the Alps look like in lockdown during one of the coldest, whitest Januaries in recent memory?

Fewer foreigners arrive in Switzerland during pandemic year

This content was published on Feb 4, 2021 While the overall number of foreigners in the country increased in 2020, the number of new arrivals fell.

Marmosets analyse ‘chats’ to find useful partners

This content was published on Feb 3, 2021 Marmosets perceive interactions with fellow marmosets as contextualised conversations, according to Zurich researchers.

Nestlé in talks with One Rock consortium on bottled water sale

This content was published on Feb 3, 2021 Nestlé is in exclusive talks with a consortium of buyers led by US private equity firm One Rock Capital to sell its North American water business.

Swiss shares can be traded again in the UK

This content was published on Feb 3, 2021 The Swiss finance ministry has removed Britain from a list of countries requiring authorisation for its securities trading platforms.

Chinese pharma firm to acquire Swiss production facility

This content was published on Feb 2, 2021 The Couvet factory in western Switzerland employs 100 staff manufacturing medicines in capsule and tablet form. It is expected to pass into WuXi’s hands for an undisclosed sum following regulatory approval in the second quarter of this year. Couvet will be the first European drugs production site for the Chinese firm, which acquired the company…

Page 481 of 2696

First … 479 480 481 482 483 … Last

Cluster: Archive

Popular Stories

Most Discussed

Cluster: Archive

More

Banking secrecy remains a business model for Swiss banks

More

Beny Steinmetz case shows how hard it is to prove corruption

More

‘The virus is always evolving’

More

Protecting livestock from predators costs Swiss taxpayers millions

More

Alpine exposure: how good are our survival tactics?

More

Fewer foreigners arrive in Switzerland during pandemic year

More

Marmosets analyse ‘chats’ to find useful partners

More

Nestlé in talks with One Rock consortium on bottled water sale

More

Swiss shares can be traded again in the UK

More

Chinese pharma firm to acquire Swiss production facility

Popular Stories

Most Discussed